Revolutionize Precision Medicine

We unravel disease mechanisms
by identifying aberrant activities
of cell signaling pathways

news

InnoSIGN receives grant of almost €700K for ovarian cancer multicenter trial

news

Institut Gustave Roussy: OncoSIGNal predicts resistance to AR targeted drugs in mCR prostate cancer

news

Erasmus MC: OncoSIGNal predicts response to BCG treatment of bladder cancer

events

Racial differences in estrogen receptor signaling pathway activity in breast cancer patients

events

Presentation of OncoSIGNal analysis of samples from NeoLBC breast cancer trial